These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29325446)

  • 1. Reduction of PTSD Symptoms With Pre-Reactivation Propranolol Therapy: A Randomized Controlled Trial.
    Brunet A; Saumier D; Liu A; Streiner DL; Tremblay J; Pitman RK
    Am J Psychiatry; 2018 May; 175(5):427-433. PubMed ID: 29325446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial.
    Roullet P; Vaiva G; Véry E; Bourcier A; Yrondi A; Dupuch L; Lamy P; Thalamas C; Jasse L; El Hage W; Birmes P
    Neuropsychopharmacology; 2021 Aug; 46(9):1643-1649. PubMed ID: 33612830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological blockade of memory reconsolidation in posttraumatic stress disorder: three negative psychophysiological studies.
    Wood NE; Rosasco ML; Suris AM; Spring JD; Marin MF; Lasko NB; Goetz JM; Fischer AM; Orr SP; Pitman RK
    Psychiatry Res; 2015 Jan; 225(1-2):31-39. PubMed ID: 25441015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol's impact on cognitive performance in post-traumatic stress disorder.
    Mahabir M; Ashbaugh AR; Saumier D; Tremblay J
    J Affect Disord; 2016 Mar; 192():98-103. PubMed ID: 26707354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trauma reactivation plus propranolol is associated with durably low physiological responding during subsequent script-driven traumatic imagery.
    Brunet A; Thomas É; Saumier D; Ashbaugh AR; Azzoug A; Pitman RK; Orr SP; Tremblay J
    Can J Psychiatry; 2014 Apr; 59(4):228-32. PubMed ID: 25007116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Oxytocin to Prevent Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial in Emergency Department Patients.
    van Zuiden M; Frijling JL; Nawijn L; Koch SBJ; Goslings JC; Luitse JS; Biesheuvel TH; Honig A; Veltman DJ; Olff M
    Biol Psychiatry; 2017 Jun; 81(12):1030-1040. PubMed ID: 28087128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.
    Yehuda R; Bierer LM; Pratchett LC; Lehrner A; Koch EC; Van Manen JA; Flory JD; Makotkine I; Hildebrandt T
    Psychoneuroendocrinology; 2015 Jan; 51():589-97. PubMed ID: 25212409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of early stress on memory reconsolidation: Implications for post-traumatic stress disorder treatment.
    Villain H; Benkahoul A; Birmes P; Ferry B; Roullet P
    PLoS One; 2018; 13(1):e0191563. PubMed ID: 29352277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial.
    Krystal JH; Rosenheck RA; Cramer JA; Vessicchio JC; Jones KM; Vertrees JE; Horney RA; Huang GD; Stock C;
    JAMA; 2011 Aug; 306(5):493-502. PubMed ID: 21813427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitating Fear-Based Memory Extinction With Dexamethasone: A Randomized Controlled Trial in Male Veterans With Combat-Related PTSD.
    Surís A; Holliday R; Adinoff B; Holder N; North CS
    Psychiatry; 2017; 80(4):399-410. PubMed ID: 29466111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol.
    Pitman RK; Sanders KM; Zusman RM; Healy AR; Cheema F; Lasko NB; Cahill L; Orr SP
    Biol Psychiatry; 2002 Jan; 51(2):189-92. PubMed ID: 11822998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery.
    Hoge EA; Worthington JJ; Nagurney JT; Chang Y; Kay EB; Feterowski CM; Katzman AR; Goetz JM; Rosasco ML; Lasko NB; Zusman RM; Pollack MH; Orr SP; Pitman RK
    CNS Neurosci Ther; 2012 Jan; 18(1):21-7. PubMed ID: 22070357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of traumatic memory reactivation with or without propranolol in PTSD with high dissociative experiences.
    Roullet P; Taïb S; Thalamas C; Vaiva G; El Hage W; Yrondi A; Birmes P
    Eur J Psychotraumatol; 2022 Dec; 13(2):2151098. PubMed ID: 38872596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory reconsolidation impairment using the β-adrenergic receptor blocker propranolol reduces nightmare severity in patients with posttraumatic stress disorder: a preliminary study.
    Mallet C; Chick CF; Maatoug R; Fossati P; Brunet A; Millet B
    J Clin Sleep Med; 2022 Jul; 18(7):1847-1855. PubMed ID: 35404227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial.
    Rodgman C; Verrico CD; Holst M; Thompson-Lake D; Haile CN; De La Garza R; Raskind MA; Newton TF
    J Clin Psychiatry; 2016 May; 77(5):e561-5. PubMed ID: 27249080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.
    Naylor JC; Kilts JD; Bradford DW; Strauss JL; Capehart BP; Szabo ST; Smith KD; Dunn CE; Conner KM; Davidson JR; Wagner HR; Hamer RM; Marx CE
    Int Clin Psychopharmacol; 2015 May; 30(3):167-74. PubMed ID: 25647451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial.
    van den Berg DP; de Bont PA; van der Vleugel BM; de Roos C; de Jongh A; Van Minnen A; van der Gaag M
    JAMA Psychiatry; 2015 Mar; 72(3):259-67. PubMed ID: 25607833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment gains of a brief exposure-based treatment for PTSD.
    Thompson-Hollands J; Marx BP; Lee DJ; Resick PA; Sloan DM
    Depress Anxiety; 2018 Oct; 35(10):985-991. PubMed ID: 30144228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Transcendental Meditation Program's Impact on the Symptoms of Post-traumatic Stress Disorder of Veterans: An Uncontrolled Pilot Study.
    Herron RE; Rees B
    Mil Med; 2018 Jan; 183(1-2):e144-e150. PubMed ID: 29401353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
    Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
    Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.